Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine-containing shortened regimens for pulmonary tuberculosis
2015-003446-45Phase 3Active
- Sponsor
- Unidad de Investigación en Tuberculosis de Barcelona
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rifapentine in pulmonary tuberculosis (TB) (2 arms), sponsored by Unidad de Investigación en Tuberculosis de Barcelona. Primary endpoint: TB disease-free survival at 12 months. Started Oct 2015; status: active.
02
Drugs
rifapentine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on 2015-003446-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003446-45.